Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC
Clinical trial NCT03780010 · COMPLETED
Trial details
- NCT number
- NCT03780010
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2019-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.